Dr. Mascarenhas on Updates from the MANIFEST Trial in Myelofibrosis - OncLive
6/11/2022 12:00:00 AM2 years 10 months ago
by John O. Mascarenhas, MD
by John O. Mascarenhas, MD
John O. Mascarenhas, MD, discusses updates from the phase 2 MANIFEST trial in patients with myelofibrosis.
John O. Mascarenhas, MD, professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, director, the Center of Excellence for Blood Cancers and Myeloid Disorders, mem… [+1115 chars]
full article...